Opioid Growth Factor Receptor (OGFR) (C-Term) Peptide
Quick Overview for Opioid Growth Factor Receptor (OGFR) (C-Term) Peptide (ABIN2184240)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Sequence
- DEPAESPSET PGPRPAGPAG DEPAESPSET PGPSPAGPTR DEPAKAGEAA
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-OGFR Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeat freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- OGFR (Opioid Growth Factor Receptor (OGFR))
-
Background
-
The protein encoded by this gene is a receptor for opioid growth factor (OGF), also known as [Met(5)]-enkephalin. OGF is a negative regulator of cell proliferation and tissue organization in a variety of processes. The encoded unbound receptor for OGF has been localized to the outer nuclear envelope, where it binds OGF and is translocated into the nucleus. The coding sequence of this gene contains a polymorphic region of 60 nt tandem imperfect repeat units. Several transcripts containing between zero and eight repeat units have been reported.
Alias Symbols: -
Protein Size: 677 -
Molecular Weight
- 73 kDa
-
Gene ID
- 11054
-
NCBI Accession
- NM_007346, NP_031372
-
UniProt
- Q9NZT2
Target
-